Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04399044 · ClinicalTrials.gov registry record · NA
Prophylactic Muscle Flaps in Vascular Surgery
A NA study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04399044: Clinical Trial NA study, sponsored by University of Wisconsin, Madison.
NCT04399044 is a NA study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04399044, a NA study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Previous studies have suggested that prophylactic muscle coverage in high-risk patients undergoing revascularization procedures through a groin incision have the potential to reduce rates of complications and re-operation. This is a prospective randomized control trial to test this hypothesis at the University of Wisconsin Hospitals and Clinics.
Primary Outcome
Infection of the vascular graft as determined by clinical diagnosis which requires re-operation for washout or other indicated procedures
Interventions
- PROCEDURE Prophylactic muscle flap
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2020-10-16 |
| Est. Completion | 2021-02-26 |
| Phase | NA |
Why NCT04399044 stopped before completion
NCT04399044 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Prophylactic muscle flap is the first listed.
NCT04399044 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04399044 about?
NCT04399044 is a clinical study titled "Prophylactic Muscle Flaps in Vascular Surgery". Previous studies have suggested that prophylactic muscle coverage in high-risk patients undergoing revascularization procedures through a groin incision have the potential to reduce rates of complications and re-operation. This is a prospective randomized control trial to test this hypothesis at the...
What is the current status of trial NCT04399044?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2020-10-16. Estimated completion is 2021-02-26.
What interventions are being tested in trial NCT04399044?
The interventions under investigation include: Prophylactic muscle flap (PROCEDURE).
Who is sponsoring clinical trial NCT04399044?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04399044's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI